Cancer Biomarker Prospects May Be Unrealistic, At Least For Now
Executive Summary
The high hopes for genomics and proteomics research to yield valid cancer biomarkers may exceed the field's current capabilities, David Ransohoff (University of North Carolina) cautioned at the Institute of Medicine's National Cancer Policy Forum